Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $770,875.00 |
|---|---|
| Enterprise Value | $7.34 Million |
| Earnings per Share | $-2 |
| Beta | 0.9 |
| Outstanding Shares | 1,927,188 |
| P/E Ratio | -0.02 |
|---|---|
| PEG | -0.1 |
| Price to Sales | - |
| Price to Book Ratio | -0.08 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.64 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | -1 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Biophytis S.A. is a clinical-stage biotechnology company dedicated to creating therapies designed to mitigate age-related degenerative processes and enhance functional well-being for patients. The company's scientific approach centers on...